CASI Pharmaceuticals, Inc. (CASIF) bonds
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Debt
Borrowings on the balance sheet, Dec 31, 2025
CASI Pharmaceuticals reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in CASI Pharmaceuticals's 20-F for the period ended May 31, 2022
CASI Pharmaceuticals's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| East West Bank | $10.00M |
See a number that looks wrong?